Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1855]
News [2824]
Articles [214]
Editorials [1]
Conferences [142]
elearning [13]
Molecular evolution of breast cancer during neoadjuvant chemotherapy
Prof Anne-Lise Børresen-Dale - Oslo University Hospital, Oslo, Norway
Molecular evolution of breast cancer during neoadjuvant chemotherapy ( Prof Anne-Lise Børresen-Dale - Oslo University Hospital, Oslo, Norway )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
Editor's choice for December 2015
Prof Gordon McVie - ecancer Editor
Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )
16 Dec 2015
Update on management of the axilla
Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA
Update on management of the axilla ( Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA )
14 Dec 2015
Peri-operative lapatinib has profound antiproliferative effect in early breast...
Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom
Peri-operative lapatinib has profound antiproliferative effect in early breast cancer ( Prof Nigel Bundred - University of Manchester, Manchester, United Kingdom )
14 Dec 2015
Guidelines and management of advanced breast cancer in limited resource settings
Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon
Guidelines and management of advanced breast cancer in limited resource settings ( Prof Nagi S. El Saghir - American University of Beirut, Beirut, Lebanon )
14 Dec 2015
New developments and technologies in hereditary cancer
Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...
New developments and technologies in hereditary cancer ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
14 Dec 2015
Results of the CREATE-X trial
Dr Masakazu Toi - Kyoto University, Kyoto, Japan
Results of the CREATE-X trial ( Dr Masakazu Toi - Kyoto University, Kyoto, Japan )
14 Dec 2015
Improved survival outcomes in women with HER2-negative breast cancer after...
Dr Masakazu Toi - Kyoto university, Kyoto, Japan
Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy ( Dr Masakazu Toi - Kyoto university, Kyoto, Japan )
10 Dec 2015
Adding carboplatin to presurgery chemotherapy improved disease-free survival...
Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer ( Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
10 Dec 2015
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant...
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
9 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation